Amsterdam, Noord-Holland, The Netherlands Holland Venture appeared to be the VC, which was created in 1981. The leading representative office of defined VC is situated in the Amsterdam. The fund was located in Europe if to be more exact in The Netherlands.
The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Holland Venture, startups are often financed by infoseek, UvA Ventures Holding, StartGreen Capital. The meaningful sponsors for the fund in investment in the same round are BOM Capital, InnovationQuarter, BOM Brabant Ventures. In the next rounds fund is usually obtained by InvestInFuture, Eindhoven Venture Capital Fund II, BOM Capital.
Speaking about the real fund results, this VC is 51 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 5 - 10 millions dollars. Opposing the other organizations, this Holland Venture works on 5 percentage points less the average amount of lead investments. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2015.
Among the most successful fund investment fields, there are Medical Device, Software. Among the various public portfolio startups of the fund, we may underline PassCall Advanced Technologies, Quantib, Cytosmart The fund has no exact preference in some founders of portfolio startups. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - The Netherlands.
| Fund Name | Location |
| Alter Equity 3P | France, Ile-de-France, Paris |
| Citation Strategic Partners | - |
| Eclectic Fund | - |
| Growth Capital Partners | England, London, United Kingdom |
| Haofang Capital | - |
| IDI | France, Ile-de-France, Paris |
| Lancaster Investments | - |
| LORD Corporation | Cary, North Carolina, United States |
| Losa Group | Guatemala, Guatemala City |
| NDRC LaunchPad | County Dublin, Dublin, Ireland |
| Purpose Venture Capital | Central, Central Region, Singapore |
| QIngluan Huifu Investment Management | Beijing, Beijing, China |
| SAMTAK | China, Jinan, Shandong |
| Spring Bay Ventures | Florida, Ponte Vedra Beach, United States |
| Technomark Medical Ventures | England, London, United Kingdom |
| The Buckeye Group | Beverly Hills, California, United States |
| Tus-S&T Service Group | Beijing, Beijing, China |
| Xietingge Touzi | Chengdu, China, Sichuan |
| Yingta Jiankang Guanli | China, Shanghai |
Discover 4 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Sirius Medical | $14M | 21 Mar 2023 | Eindhoven, Noord-Brabant, The Netherlands | ||
Channext | $5M | 27 Sep 2022 | Rotterdam, Zuid-Holland, The Netherlands | ||
Open HealthHub | 26 Jul 2022 | Leusden, Utrecht, The Netherlands | |||
Sirius Medical | 14 Dec 2021 | Eindhoven, Noord-Brabant, The Netherlands | |||
Sirius Medical | $5M | 13 Jul 2020 | Eindhoven, Noord-Brabant, The Netherlands | ||
Cytosmart | $6M | 25 Mar 2019 | Eindhoven, North Brabant, Netherlands | ||
Prolira BV | $2M | 01 Nov 2018 | Utrecht, Utrecht, Netherlands | ||
Quantib | $5M | 27 Nov 2017 | Rotterdam, South Holland, Netherlands | ||
Autheos | 01 Jul 2016 | Amsterdam, Noord-Holland, The Netherlands |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Sirius Medical | $14M | 21 Mar 2023 | Eindhoven, Noord-Brabant, The Netherlands | ||
Channext | $5M | 27 Sep 2022 | Rotterdam, Zuid-Holland, The Netherlands | ||
Open HealthHub | 26 Jul 2022 | Leusden, Utrecht, The Netherlands | |||
Sirius Medical | 14 Dec 2021 | Eindhoven, Noord-Brabant, The Netherlands | |||
Sirius Medical | $5M | 13 Jul 2020 | Eindhoven, Noord-Brabant, The Netherlands | ||
Cytosmart | $6M | 25 Mar 2019 | Eindhoven, North Brabant, Netherlands | ||
Prolira BV | $2M | 01 Nov 2018 | Utrecht, Utrecht, Netherlands | ||
Quantib | $5M | 27 Nov 2017 | Rotterdam, South Holland, Netherlands | ||
Autheos | 01 Jul 2016 | Amsterdam, Noord-Holland, The Netherlands |
